« Back
Home /
MLN8237 (Alisertib)

MLN8237 (Alisertib)

Item no.	M1752-100mg
Manufacturer	AbMole
CASRN	1028486-01-2
Amount	100mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	0,9917
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Alisertib
Similar products	MLN8237, Alisertib
Available
Target Information	Aurora Kinase
Molecular Weight	518, 92
Solubility	DMSO 26 mg/mL
Bioactivity information	MLN8237 (Alisertib) is a second-generation, orally bioavailable, highly selective Aurora kinase A inhibitor with IC50 of 61 nM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1752-100mg-safety-datasheet.pdf